Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Kelly Maloney

Concepts (374)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
40
2025
299
5.480
 Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
11
2025
91
1.610
 Why?
Down Syndrome
6
2023
529
1.210
 Why?
Antineoplastic Combined Chemotherapy Protocols
18
2026
1996
1.210
 Why?
Leukemia, Myeloid, Acute
8
2026
700
1.010
 Why?
Burkitt Lymphoma
3
2024
61
0.920
 Why?
Asparaginase
8
2020
34
0.810
 Why?
Fishes
1
2024
111
0.790
 Why?
Agriculture
1
2024
94
0.780
 Why?
Child
75
2026
22638
0.740
 Why?
Bayes Theorem
1
2024
424
0.710
 Why?
Consolidation Chemotherapy
2
2019
11
0.640
 Why?
Child, Preschool
50
2026
11888
0.610
 Why?
Ecosystem
1
2024
483
0.600
 Why?
Neoplasm Recurrence, Local
6
2025
1156
0.600
 Why?
Disease-Free Survival
12
2024
777
0.540
 Why?
Leukemia
4
2021
246
0.530
 Why?
Oncogene Proteins, Fusion
6
2024
212
0.520
 Why?
Mercaptopurine
5
2017
15
0.500
 Why?
Prognosis
17
2026
4331
0.500
 Why?
Recurrence
12
2025
1125
0.450
 Why?
Antineoplastic Agents
7
2019
2218
0.450
 Why?
Infant
36
2026
10093
0.450
 Why?
Preleukemia
1
2015
2
0.440
 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
2016
128
0.430
 Why?
Drug Hypersensitivity
3
2017
93
0.420
 Why?
Molecular Targeted Therapy
3
2021
446
0.420
 Why?
Leukemia, Monocytic, Acute
1
2014
3
0.420
 Why?
Sarcoma, Myeloid
1
2014
6
0.410
 Why?
Adolescent
43
2026
22451
0.410
 Why?
Neoplasm, Residual
7
2023
143
0.400
 Why?
Bone Marrow Transplantation
1
2014
298
0.370
 Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
2023
25
0.360
 Why?
Erwinia
2
2020
3
0.350
 Why?
Humans
87
2026
145625
0.350
 Why?
Medical Oncology
5
2025
344
0.350
 Why?
Tumor Suppressor Proteins
3
1999
314
0.350
 Why?
Chromosome Aberrations
2
2022
167
0.340
 Why?
Acute Kidney Injury
1
2019
861
0.340
 Why?
Male
59
2026
73014
0.330
 Why?
Neutropenia
2
2022
153
0.330
 Why?
Stem Cell Transplantation
3
2019
189
0.320
 Why?
Hematopoietic Stem Cell Transplantation
2
2019
700
0.320
 Why?
Rhabdomyosarcoma
1
2011
65
0.310
 Why?
Cell Cycle Proteins
3
1999
629
0.310
 Why?
Carrier Proteins
3
1999
728
0.310
 Why?
Sarcoma, Ewing
1
2011
103
0.300
 Why?
Biomarkers, Tumor
3
2026
1334
0.300
 Why?
Ploidies
2
2019
21
0.300
 Why?
Lymphoma, Large B-Cell, Diffuse
2
2022
195
0.290
 Why?
Core Binding Factor Alpha 2 Subunit
3
2021
32
0.280
 Why?
Genes, Tumor Suppressor
2
1999
84
0.280
 Why?
Female
57
2026
79080
0.280
 Why?
Catheter-Related Infections
2
2022
98
0.280
 Why?
Survival Rate
8
2024
2078
0.280
 Why?
Cyclophosphamide
4
2019
275
0.270
 Why?
Catheterization, Central Venous
2
2022
120
0.260
 Why?
Philadelphia Chromosome
2
2018
18
0.260
 Why?
Medication Adherence
3
2017
535
0.250
 Why?
Gene Deletion
2
1998
384
0.240
 Why?
Vincristine
4
2021
148
0.230
 Why?
Neoplasm Proteins
2
2018
443
0.230
 Why?
Trisomy
2
2021
79
0.230
 Why?
Etoposide
2
2019
169
0.230
 Why?
Antimetabolites, Antineoplastic
2
2017
108
0.230
 Why?
Ikaros Transcription Factor
1
2025
23
0.220
 Why?
Young Adult
15
2024
14240
0.210
 Why?
Maryland
1
2024
67
0.210
 Why?
Invertebrates
1
2024
21
0.210
 Why?
Cyclin-Dependent Kinase Inhibitor p16
3
1999
74
0.200
 Why?
Rivers
1
2024
62
0.200
 Why?
Treatment Outcome
12
2023
11744
0.200
 Why?
PAX5 Transcription Factor
2
2024
15
0.200
 Why?
Anxiety
3
2016
1118
0.200
 Why?
Polymorphism, Single Nucleotide
4
2025
2228
0.190
 Why?
Genomics
4
2025
851
0.190
 Why?
Gene Rearrangement
3
2019
155
0.180
 Why?
Polyethylene Glycols
5
2020
649
0.180
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2023
76
0.180
 Why?
Leukemia, Myelomonocytic, Juvenile
1
2022
4
0.180
 Why?
Induction Chemotherapy
2
2019
87
0.170
 Why?
Environmental Monitoring
1
2024
346
0.170
 Why?
Central Venous Catheters
1
2022
53
0.170
 Why?
Health Equity
1
2024
139
0.170
 Why?
Program Evaluation
2
2017
945
0.170
 Why?
Prednisone
2
2019
229
0.170
 Why?
Lymphoma
1
2023
251
0.160
 Why?
Doxorubicin
2
2022
414
0.160
 Why?
Lung Neoplasms
1
2014
2674
0.160
 Why?
Adult
23
2023
40821
0.160
 Why?
Translocation, Genetic
2
2013
126
0.150
 Why?
Maintenance Chemotherapy
2
2017
41
0.150
 Why?
Bacterial Infections
1
2022
246
0.150
 Why?
Immunocompromised Host
1
2021
201
0.150
 Why?
Diploidy
1
2019
19
0.150
 Why?
Genes, p16
1
1999
13
0.150
 Why?
Risk Factors
11
2022
10840
0.150
 Why?
Hyperglycemia
1
2023
381
0.140
 Why?
Chromosomes, Human, Pair 19
1
1998
27
0.140
 Why?
Quality of Life
3
2024
3187
0.140
 Why?
Chromosomes, Human, Pair 17
1
1998
54
0.140
 Why?
Rituximab
1
2019
208
0.140
 Why?
Antibodies, Bispecific
1
2019
70
0.140
 Why?
Chromosomes, Human, Pair 1
1
1998
81
0.140
 Why?
Prospective Studies
9
2022
8087
0.140
 Why?
Myelodysplastic Syndromes
1
2020
170
0.130
 Why?
Mutagenesis
1
1999
196
0.130
 Why?
Prostate-Specific Antigen
2
2009
162
0.130
 Why?
Substance Withdrawal Syndrome
1
2020
184
0.130
 Why?
Proto-Oncogenes
1
1997
27
0.130
 Why?
Patient Safety
1
2021
351
0.130
 Why?
Family Relations
2
2016
87
0.130
 Why?
Retrospective Studies
11
2026
17291
0.130
 Why?
Thioguanine
1
2017
18
0.130
 Why?
Thionucleotides
1
2017
35
0.130
 Why?
Apyrase
1
2017
27
0.130
 Why?
Oncologists
1
2017
47
0.120
 Why?
Blast Crisis
1
2016
34
0.120
 Why?
Carboxypeptidases A
1
2016
2
0.120
 Why?
Follow-Up Studies
6
2021
5397
0.120
 Why?
Pediatricians
1
2017
120
0.120
 Why?
Gene Expression Regulation, Enzymologic
1
2017
266
0.120
 Why?
Adrenal Cortex Hormones
1
2019
483
0.110
 Why?
Osteonecrosis
1
2015
23
0.110
 Why?
Sepsis
1
2022
668
0.110
 Why?
Nausea
1
2016
111
0.110
 Why?
Mentors
2
2017
215
0.110
 Why?
Depression
2
2016
1566
0.110
 Why?
Cohort Studies
6
2026
6045
0.110
 Why?
Monitoring, Physiologic
1
2017
278
0.110
 Why?
Pancreatitis
1
2016
146
0.110
 Why?
Central Nervous System Neoplasms
1
2017
177
0.110
 Why?
Dexamethasone
4
2021
368
0.110
 Why?
Fusion Proteins, bcr-abl
2
2016
68
0.110
 Why?
Mentoring
1
2017
165
0.110
 Why?
Mutation
4
2022
4082
0.110
 Why?
Longitudinal Studies
7
2016
3005
0.110
 Why?
Cyclin-Dependent Kinase Inhibitor p15
3
1999
14
0.100
 Why?
Myeloid-Lymphoid Leukemia Protein
2
2010
72
0.100
 Why?
High-Throughput Nucleotide Sequencing
1
2017
538
0.100
 Why?
Bacteremia
1
2016
218
0.100
 Why?
Flow Cytometry
1
2018
1160
0.100
 Why?
Repressor Proteins
1
1997
428
0.100
 Why?
Cross Infection
1
2016
258
0.100
 Why?
Antigens, CD
1
2017
559
0.100
 Why?
Life Change Events
1
2014
144
0.100
 Why?
Chromosomes, Human, Pair 21
1
2013
43
0.100
 Why?
DNA-Binding Proteins
2
1998
1467
0.100
 Why?
Histone-Lysine N-Methyltransferase
2
2010
141
0.100
 Why?
Pediatrics
3
2021
1122
0.100
 Why?
Immunotherapy
1
2018
669
0.090
 Why?
Risk Assessment
5
2026
3678
0.090
 Why?
Leukemia, Megakaryoblastic, Acute
1
2012
10
0.090
 Why?
Venous Thromboembolism
1
2017
330
0.090
 Why?
Transcription Factors
2
1998
1728
0.090
 Why?
Myeloproliferative Disorders
1
2012
21
0.090
 Why?
Karyotyping
3
2019
106
0.090
 Why?
Self Report
1
2017
869
0.090
 Why?
Quality Improvement
1
2021
1325
0.090
 Why?
Contraindications
1
2012
88
0.090
 Why?
Arabinonucleosides
1
2011
8
0.090
 Why?
Adenine Nucleotides
1
2011
21
0.090
 Why?
Prostatic Neoplasms
2
2009
972
0.080
 Why?
Antibodies, Monoclonal
1
2018
1511
0.080
 Why?
Chromosomes, Human, Pair 4
1
2010
26
0.080
 Why?
Chromosomes, Human, Pair 10
1
2010
21
0.080
 Why?
Pain
1
2016
787
0.080
 Why?
Multivariate Analysis
4
2015
1531
0.080
 Why?
T-Lymphocytes
1
2018
2007
0.070
 Why?
Parents
2
2016
1393
0.070
 Why?
Age Factors
8
2019
3321
0.070
 Why?
Prostatectomy
1
2009
93
0.070
 Why?
Bloom Syndrome
1
1988
3
0.070
 Why?
Neoplasm Metastasis
1
2011
693
0.070
 Why?
Juxtaglomerular Apparatus
1
2007
2
0.070
 Why?
Gene Expression Regulation, Leukemic
2
2016
56
0.070
 Why?
Polymerase Chain Reaction
1
2010
1030
0.060
 Why?
Drug Administration Schedule
2
2017
782
0.060
 Why?
Blood Coagulation
1
2008
267
0.060
 Why?
Clinical Trials, Phase III as Topic
1
2026
116
0.060
 Why?
Stress, Psychological
1
2014
1169
0.060
 Why?
Surveys and Questionnaires
4
2024
6050
0.060
 Why?
Clinical Trials as Topic
2
2024
1062
0.060
 Why?
Animals
3
2024
38030
0.060
 Why?
Methotrexate
2
2017
234
0.060
 Why?
Remission Induction
2
2019
308
0.050
 Why?
Case-Control Studies
3
2024
3633
0.050
 Why?
Acute Disease
2
2019
1033
0.050
 Why?
Selection Bias
1
2024
38
0.050
 Why?
United States
5
2026
16041
0.050
 Why?
Personal Satisfaction
2
2017
218
0.050
 Why?
Incidence
3
2019
2910
0.050
 Why?
Genetic Variation
1
1988
992
0.050
 Why?
Administration, Oral
2
2017
867
0.050
 Why?
Kidney Neoplasms
1
2007
417
0.050
 Why?
Risk
5
2023
917
0.050
 Why?
Drug Monitoring
2
2017
399
0.050
 Why?
Disease Progression
2
2021
2857
0.040
 Why?
Proto-Oncogene Proteins c-cbl
1
2022
13
0.040
 Why?
Randomized Controlled Trials as Topic
2
2020
1754
0.040
 Why?
Exome
1
2022
232
0.040
 Why?
Menorrhagia
1
2001
22
0.040
 Why?
Drug Therapy
1
2021
85
0.040
 Why?
Transcriptome
2
2019
1066
0.040
 Why?
Diarrhea
2
1999
190
0.040
 Why?
Bone Marrow
1
2022
308
0.040
 Why?
Endocrine Glands
1
1979
14
0.040
 Why?
Blood Cell Count
1
1999
56
0.040
 Why?
Chromosomes, Human
1
2019
45
0.040
 Why?
Cytogenetic Analysis
1
2019
34
0.040
 Why?
Loss of Heterozygosity
1
1999
51
0.040
 Why?
Azacitidine
1
2020
168
0.040
 Why?
Viral Load
1
2021
525
0.040
 Why?
Mosaicism
1
2019
67
0.040
 Why?
Genome-Wide Association Study
2
2016
1526
0.030
 Why?
Sequence Deletion
1
1999
190
0.030
 Why?
Hypertension
1
2007
1270
0.030
 Why?
Disinfectants
1
1999
45
0.030
 Why?
National Cancer Institute (U.S.)
1
2018
55
0.030
 Why?
Chromosomes
1
2019
105
0.030
 Why?
Escherichia coli O157
1
1998
14
0.030
 Why?
Bridged Bicyclo Compounds, Heterocyclic
1
2020
291
0.030
 Why?
Infant, Newborn
4
2019
6449
0.030
 Why?
Methylation
1
1998
241
0.030
 Why?
Overweight
1
2023
613
0.030
 Why?
Biopsy
1
2021
1073
0.030
 Why?
Community Participation
1
1999
128
0.030
 Why?
Erythrocyte Count
1
2017
20
0.030
 Why?
Interviews as Topic
1
2021
926
0.030
 Why?
Glucose
1
2023
1051
0.030
 Why?
Genetic Predisposition to Disease
2
2017
2455
0.030
 Why?
Escherichia coli Infections
1
1998
125
0.030
 Why?
Public Health Surveillance
1
2017
84
0.030
 Why?
Food-Drug Interactions
1
2017
11
0.030
 Why?
Proto-Oncogene Proteins c-ets
1
1997
54
0.030
 Why?
Career Mobility
1
2017
68
0.030
 Why?
Injections, Intramuscular
1
2017
140
0.030
 Why?
Leucovorin
1
2017
98
0.030
 Why?
Dairy Products
1
2017
30
0.030
 Why?
Cerebrospinal Fluid
1
2017
88
0.030
 Why?
MEF2 Transcription Factors
1
2016
51
0.030
 Why?
Water Purification
1
1999
156
0.030
 Why?
Cranial Irradiation
1
2017
85
0.030
 Why?
Family
1
2021
680
0.030
 Why?
Leukocyte Count
1
2017
319
0.030
 Why?
Infusions, Intravenous
1
2017
429
0.030
 Why?
Luciferases
1
2016
153
0.030
 Why?
NIH 3T3 Cells
1
2016
146
0.030
 Why?
Methyltransferases
1
2017
73
0.030
 Why?
Feasibility Studies
1
2021
1125
0.030
 Why?
Sulfonamides
1
2020
592
0.030
 Why?
Ethers
1
1996
19
0.030
 Why?
Methyl Ethers
1
1996
19
0.030
 Why?
Bone Morphogenetic Protein 7
1
2015
12
0.030
 Why?
Fluorides
1
1996
50
0.030
 Why?
Cytarabine
1
2016
66
0.030
 Why?
Health Education
1
1999
346
0.030
 Why?
Hemorrhage
1
2001
824
0.030
 Why?
Genotype
3
2017
1866
0.030
 Why?
Anesthetics, Inhalation
1
1996
52
0.030
 Why?
Severity of Illness Index
2
2017
2910
0.030
 Why?
Breast Neoplasms
5
1979
2411
0.030
 Why?
Histone Deacetylase Inhibitors
1
2016
218
0.030
 Why?
Spinal Dysraphism
1
1996
113
0.030
 Why?
Disease Management
1
2019
649
0.030
 Why?
Alternative Splicing
1
2017
249
0.030
 Why?
Middle Aged
10
2019
36359
0.030
 Why?
Homeodomain Proteins
1
1998
525
0.030
 Why?
HEK293 Cells
1
2017
746
0.030
 Why?
Promoter Regions, Genetic
1
1999
1236
0.030
 Why?
Sequence Analysis, RNA
1
2016
441
0.030
 Why?
Intensive Care Units, Pediatric
1
2016
293
0.030
 Why?
DNA Methylation
1
1999
721
0.020
 Why?
Psychomotor Agitation
1
2014
43
0.020
 Why?
Qualitative Research
1
2021
1720
0.020
 Why?
Behavior
1
2014
90
0.020
 Why?
Demography
1
2014
274
0.020
 Why?
Income
1
2014
205
0.020
 Why?
Algorithms
1
2021
1843
0.020
 Why?
Marriage
1
2014
122
0.020
 Why?
Base Sequence
1
2016
2119
0.020
 Why?
Aged
9
2019
26251
0.020
 Why?
Odds Ratio
1
2015
1070
0.020
 Why?
Blood Glucose
1
2023
2357
0.020
 Why?
Aggression
1
2014
170
0.020
 Why?
In Situ Hybridization, Fluorescence
1
2013
333
0.020
 Why?
Prevalence
2
2016
2852
0.020
 Why?
Nucleoside Transport Proteins
1
2011
9
0.020
 Why?
Kidney
2
1996
1491
0.020
 Why?
Regression Analysis
1
2014
994
0.020
 Why?
Time Factors
2
2015
7079
0.020
 Why?
Antineoplastic Agents, Alkylating
1
2011
76
0.020
 Why?
Escherichia coli
1
2015
831
0.020
 Why?
Erythrocytes
1
2017
749
0.020
 Why?
Bacteria
1
2016
766
0.020
 Why?
Antineoplastic Agents, Phytogenic
1
2011
178
0.020
 Why?
Mice
2
2019
18266
0.020
 Why?
Survival Analysis
1
2013
1372
0.020
 Why?
Logistic Models
1
2015
2112
0.020
 Why?
Obesity
1
2023
3123
0.020
 Why?
Kaplan-Meier Estimate
1
2011
959
0.020
 Why?
Sister Chromatid Exchange
1
1988
4
0.020
 Why?
Emotions
1
2014
555
0.020
 Why?
Cell Fusion
1
1988
47
0.020
 Why?
Genetic Complementation Test
1
1988
72
0.020
 Why?
Plasminogen Activator Inhibitor 1
1
2008
83
0.020
 Why?
Protein C
1
2008
54
0.020
 Why?
Water Microbiology
2
1999
86
0.020
 Why?
Antithrombins
1
2008
70
0.020
 Why?
Mice, Inbred C57BL
1
2019
6021
0.020
 Why?
Genetic Markers
1
1988
337
0.020
 Why?
Fibrinogen
1
2008
181
0.020
 Why?
Renin-Angiotensin System
1
2007
80
0.020
 Why?
Biopsy, Needle
1
2007
182
0.020
 Why?
Transplantation, Homologous
1
2008
415
0.020
 Why?
Rare Diseases
1
2007
115
0.020
 Why?
Blood Pressure Determination
1
2007
143
0.020
 Why?
Nephrectomy
1
2007
169
0.010
 Why?
Biomarkers
1
2017
4329
0.010
 Why?
RNA, Messenger
1
2011
2783
0.010
 Why?
Immunohistochemistry
1
2007
1709
0.010
 Why?
Cell Line
1
1988
2809
0.010
 Why?
Anemia, Hypochromic
1
2001
2
0.010
 Why?
Blood Platelet Disorders
1
2001
10
0.010
 Why?
von Willebrand Diseases
1
2001
28
0.010
 Why?
Estriol
1
1979
5
0.010
 Why?
Estrone
1
1979
41
0.010
 Why?
Menstruation
1
1979
44
0.010
 Why?
Prolactin
1
1979
88
0.010
 Why?
Thrombocytopenia
1
2001
205
0.010
 Why?
Bolivia
1
1999
64
0.010
 Why?
Luteinizing Hormone
1
1979
206
0.010
 Why?
Food Handling
1
1998
33
0.010
 Why?
Progesterone
1
1979
214
0.010
 Why?
Restaurants
1
1998
25
0.010
 Why?
Swimming
1
1998
54
0.010
 Why?
Follicle Stimulating Hormone
1
1979
265
0.010
 Why?
Disease Transmission, Infectious
1
1998
69
0.010
 Why?
Meat
1
1998
62
0.010
 Why?
Water Supply
1
1998
90
0.010
 Why?
Kyphosis
1
1996
37
0.010
 Why?
Halothane
1
1996
8
0.010
 Why?
Analysis of Variance
1
1999
1293
0.010
 Why?
Estradiol
1
1979
517
0.010
 Why?
Congenital Abnormalities
1
1996
108
0.010
 Why?
Population Surveillance
1
1999
477
0.010
 Why?
Feces
1
1998
494
0.010
 Why?
Diagnostic Imaging
1
1996
340
0.010
 Why?
Ovarian Neoplasms
1
1978
598
0.010
 Why?
Pedigree
3
1978
507
0.010
 Why?
Nebraska
2
1976
21
0.000
 Why?
Aged, 80 and over
1
1999
8351
0.000
 Why?
New York
2
1976
127
0.000
 Why?
Genes
1
1978
215
0.000
 Why?
Genetic Linkage
1
1978
269
0.000
 Why?
Oncogenic Viruses
1
1976
3
0.000
 Why?
Apocrine Glands
1
1976
5
0.000
 Why?
Genetic Techniques
1
1976
64
0.000
 Why?
Pheochromocytoma
1
1976
67
0.000
 Why?
Statistics as Topic
1
1976
277
0.000
 Why?
Syndrome
1
1976
377
0.000
 Why?
Klinefelter Syndrome
1
1976
68
0.000
 Why?
HLA Antigens
1
1976
241
0.000
 Why?
Skin Diseases
1
1976
144
0.000
 Why?
Abnormalities, Multiple
1
1976
193
0.000
 Why?
Pregnancy
2
1978
7217
0.000
 Why?
Sarcoma
1
1976
209
0.000
 Why?
Sex Factors
1
1978
2101
0.000
 Why?
Thyroid Neoplasms
1
1976
380
0.000
 Why?
Neoplasms
2
1976
2944
0.000
 Why?
Melanoma
1
1976
764
0.000
 Why?
Phenotype
1
1976
3186
0.000
 Why?
Registries
1
1976
2382
0.000
 Why?
Brain Neoplasms
1
1976
1324
0.000
 Why?
Maloney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (374) concept(s)
_
Co-Authors Expand Description
See all (18) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)